Author :
Publisher :
ISBN 13 :
Total Pages : 20 pages
Book Rating : 4.:/5 (227 download)
Book Synopsis Gynecologic Cancer Center for Racial Disparities by :
Download or read book Gynecologic Cancer Center for Racial Disparities written by and published by . This book was released on 2006 with total page 20 pages. Available in PDF, EPUB and Kindle. Book excerpt: There are significant health-related disparities in outcome among women in the United States with different types of gynecologic cancer. The authors hypothesize that a poor outcome among minorities with gynecologic cancer exists because of biological differences in tumors related to race and ethnicity; cultural, social, and psychological barriers to accessing care; less than optimal screening services and prevention strategies; and unequal provision of quality health care and tailored therapeutics. To find out more about these issues, the authors will conduct an analysis of the genomic and proteomic expression of gynecologic cancers to determine if there are molecular differences that partially account for the poor outcome among minority patients with gynecologic cancer. This analysis will be expanded in future years to include larger underserved cohorts. The comprehensive epidemiological data that it generates will facilitate more detailed genetic and epigenetic analysis. Epidemiological surveys will be used to identify demographic and behavioral differences that lead to poor outcomes. An evaluation also will be conducted on the use of psychosocial interventions to decrease morbidity among minorities. The authors also will develop vaccine strategies and specific antibody reagents for the detection of unique targets that are differentially expressed between African Americans and Caucasians with endometrial cancer. The incidence, severity, and overall burden of cancer in the United States vary by race, ethnicity, and other demographic features. This project will focus on identifying the reasons underlying poor outcomes among minority groups with gynecologic malignancy so that education, screening, prevention, and treatment algorithms can be tailored to high-risk populations in an effort to have the greatest impact on reducing morbidity and mortality among the underserved.